title: [Intratympanic dexamethasone injections for intractable sudden sensorineural hearing loss].
abstract: OBJECTIVE
  To investigate the efficacy of intratympanic dexamethasone injection (IDI) for 23 patients with intractable sudden sensorineural hearing loss (SSNHL).
  
  
  METHODS
  Dexamethasone (5 g/ml) was injected into the middle ear. The injection was repeated once two days and had a total of 4 doses (10 mg).
  
  
  RESULTS
  The 23 patients were followed up for one month. Eight of 23 patients (34.8%) demonstrated a 17 to approximately 54 dB improvement in PTA and 15 of 23 (65.2%) had no response.
  
  
  CONCLUSIONS
  IDI is a simple and effective treatment for SSNHL patient who had not responded to conventional therapy, although hearing was rarely improved to normal levels.
authors.affiliation: Department of Otolaryngology, the Second Hospital of Xiangya Medical College, Central South University, Changsha, 410011, China. lihao5114@sina.com
authors.forename: Jihao
authors.initials: J
authors.lastname: Ren
authors.forename: Yongde
authors.initials: Y
authors.lastname: Lu
authors.forename: Tuanfang
authors.initials: T
authors.lastname: Yin
authors.forename: Bin
authors.initials: B
authors.lastname: Liu
authors.forename: Yilin
authors.initials: Y
authors.lastname: Ge
mesh_terms: D000328:Adult; D000368:Aged; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004432:Ear, Middle; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged
chemical_list: D003907:Dexamethasone